Cargando…

Erythrodermic psoriasis after COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Trepanowski, Nicole, Coleman, Emily L., Melson, Gabriella, Brem, Candice E., Lam, Christina S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Notes & Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364664/ https://www.ncbi.nlm.nih.gov/pubmed/35966353 http://dx.doi.org/10.1016/j.jdcr.2022.07.041

Ejemplares similares

31047 Erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine
por: Pabón-Cartagena, Gabriela, et al.
Publicado: (2022)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2022)

Erythroderme Psoriasis nach COVID-19-Erkrankung
por: Demiri, Jeta, et al.
Publicado: (2021)

Erythrodermic psoriasis after discontinuation of ixekizumab
por: Potter, Kathryn Anne, et al.
Publicado: (2017)

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis
por: Boekel, Laura
Publicado: (2022)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

Updates on the Treatment of Erythrodermic Psoriasis
por: Lo, Yang, et al.
Publicado: (2021)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

The Management of Erythrodermic Psoriasis Complicated by Cyclosporine
por: Rao, Suman, et al.
Publicado: (2020)

Organizing Pneumonia Complicated with Erythrodermic Psoriasis
por: Nakamura, Hiroyuki, et al.
Publicado: (2019)

Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
por: Chiang, Cheng-Ying, et al.
Publicado: (2021)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
por: Singh, Rasnik K, et al.
Publicado: (2016)

Respiratory Distress Syndrome Associated with Erythrodermic Psoriasis
por: Noure, Lamya, et al.
Publicado: (2021)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
por: Drago, Francesco, et al.
Publicado: (2022)

Indolent cutaneous lymphoma with gamma/delta expression after COVID-19 vaccination
por: Hobayan, Catherine Grace, et al.
Publicado: (2022)

Herpes zoster dermatitis in a COVID-19 vaccinated healthy man after 1 dose of varicella vaccine
por: Etaee, Farshid, et al.
Publicado: (2022)

Erythrodermic Psoriasis Treated with Golimumab: A Case Report
por: Lee, Won-Ku, et al.
Publicado: (2015)

Erythrodermic presentation of psoriasis in a patient treated with dupilumab
por: Tracey, Elisabeth H., et al.
Publicado: (2018)

Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019)

Erythrodermic Psoriasis Causing Uric Acid Crystal Nephropathy
por: Ellis, John, et al.
Publicado: (2019)

Erythrodermic psoriasis in post-coronavirus disease 2019 patient
por: Batubara, Irwan Saputra, et al.
Publicado: (2022)

An Uncommon Presentation of Erythrodermic Psoriasis in a Patient Without a History of Psoriasis
por: Rendo, Matt, et al.
Publicado: (2019)

Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia
por: Koumaki, Dimitra, et al.
Publicado: (2021)

Comment on “Multibacillary leprosy unmasked by COVID-19 vaccination”
por: Hanumanthu, Vinod, et al.
Publicado: (2022)

Multiple drugs: COVID-19, psoriasis vulgaris flare-up and exacerbation of psoriasis vulgaris led to erythrodermic psoriasis: 2 case reports
Publicado: (2022)

Erythrodermic Psoriasis Improved by Ustekinumab: A Report of Two Cases
por: Kim, Ye Seul, et al.
Publicado: (2016)

Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis
por: Chen, Stella X, et al.
Publicado: (2017)

Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges
por: Valenzuela, Fernando, et al.
Publicado: (2018)

Erythrodermic Psoriasis and Staph-Infective Endocarditis—A Conundrum in Succession
por: Patel, Arti, et al.
Publicado: (2022)

Bullous Pemphigoid Associated with Erythrodermic Psoriasis: A Case Report
por: Chen, Wenjuan, et al.
Publicado: (2022)

Erythrodermic Psoriasis Following SARS-CoV-2 Infection
por: Fatima-Zahra, A., et al.
Publicado: (2022)

Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
por: Lu, Xujun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k7fmnq1r2olm61qlk633kp9amk